Toggle Main Menu Toggle Search

Open Access padlockePrints

Use of imatinib mesylate in patients with CML in chronic phase resistant to interferon-alfa: Factors defined at start of therapy that predict disease progression and survival

Lookup NU author(s): Professor Stephen O'Brien


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Marin D, Marktel S, O'Brien SG, Olavarria E, Apperley J, Goldman J

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 44th Annual Meeting of the American Society of Hematology

Year of Conference: 2002

Pages: 326B-326B

Publisher: Blood: American Society of Hematology

Notes: Abstract 4853

Library holdings: Search Newcastle University Library for this item